The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major pharmaceutical ... Roche AG, and UCB SA are heavily investing in research ...

Chiesi, the international research-focused biopharmaceutical Group, announces the appointment of three new independent Non-Executive Directors (NEDs) to its Board: Roch Doliveux, Paolo Pucci and ...

The authors would like to thank Dirk Thomas, Schwarz Biosciences GmbH, Niels Krebsfaenger, Schwarz Biosciences GmbH, Christian Wolff, UCB Pharma SA and Alain Matagne UCB Pharma SA for their ...

Unichem SA Pty Ltd became a subsidiary of the company. In the year 2004, they restructured Unisearch and launched Unisearch CD Division. In the year 2005, the company set up a New Pharma ...

In a report released today, Charles Pitman CFA from Barclays reiterated a Buy rating on UCB SA (0NZT – Research Report), with a price target of ...

In a report released today, Charles Pitman CFA from Barclays reiterated a Buy rating on UCB SA (0NZT – Research Report), with a price target of €240.00. The company’s shares closed last ...

Mark Bodmer and Jonathan Lewis of UCB pharma talk us though the partnering model at UCB, and how partnering can drive innovation. The world is changing and it’s no different for the ...

United Commercial Bank (UCB) PLC held a three-day "Annual Business Conclave 2025" for its branch managers at the Rajendrapur BRAC CDM in Gazipur today. The event, themed "Rise Above the Rest ...

This page features the latest news about the UCB ADR stock. UCB showcases new data for gMG management at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM ...